drugset / Trial / NCT01119534

Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

NCT01119534

Phase 3 Unknown 270 enrolled Azidus Brasil
RandomizedParallel-groupOpen-labelTreatment

Summary

It is believed that the suppository consisting of guaiacol, menthol, camphor and eucalyptol, by their pharmacological properties already established for each component, has the ability to reduce the signs and symptoms related to upper respiratory infections in a manner equivalent (not inferior) to medicine used as a comparator in this study and higher than the suppository containing only guaiacol concentration of 12.5 mg.

Timeline

Start
2011-05
Primary completion
2011-10
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Guaiacol Small molecule
Comparator Guaifenesin Small molecule 4.19 ml
Subject Menthol Small molecule
Subject camphor Unknown
Subject eucalyptol Small molecule

Indications

No indication recorded.